Some studies have suggested that these comorbidities are marked by an imbalance of circulating cytokines, with IBS patients showing elevated serum inflammatory cytokines (IL-6, IL-8, and TNF-α) and decreased serum anti-inflammatory cytokines (IL-10) relative to healthy controls [23,24,25]. This evidence concerns the gene IL6 and irritable bowel syndrome.